Hypoxia increases Annexin A2 expression in osteoblastic cells via VEGF and ERK

Bone

Volumn 47, Issue 6, 2010, Pages 1013-1019

  Genetos, Damian C ^a   Wong, Alice ^a   Watari, Shinya ^a   Yellowley, Clare E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Annexin A2; ERK; Hypoxia; Osteoblast; Src; VEGF

Indexed keywords

DEFEROXAMINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LIPOCORTIN 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPILIN 1; NEUROPILIN 2; PROTEIN; PROTEIN TYROSINE KINASE; RECOMBINANT VASCULOTROPIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 120; VASCULOTROPIN 164; VASCULOTROPIN ANTIBODY; VASCULOTROPIN R1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL HYPOXIA; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OXYGEN TENSION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

ANIMALS; ANNEXIN A2; CELL HYPOXIA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; OSTEOBLASTS; OXYGEN; PROTEIN ISOFORMS; PROTEIN STABILITY; RNA, MESSENGER; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 78049423866     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.08.024     Document Type: Article

References (63)

1. Kronenberg H.M. Developmental regulation of the growth plate. Nature 2003, 423:332-336.
2. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z., Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999, 5:623-628.
3. Akeno N., Czyzyk-Krzeska M.F., Gross T.S., Clemens T.L. Hypoxia induces vascular endothelial growth factor gene transcription in human osteoblast-like cells through the hypoxia-inducible factor-2alpha. Endocrinology 2001, 142:959-962.
4. Gerke V., Moss S.E. Annexins and membrane dynamics. Biochim Biophys Acta 1997, 1357:129-154.
5. Gerke V., Moss S.E. Annexins: from structure to function. Physiol Rev 2002, 82:331-371.
6. Haut Donahue T.L., Genetos D.C., Jacobs C.R., Donahue H.J., Yellowley C.E. Annexin V disruption impairs mechanically induced calcium signaling in osteoblastic cells. Bone 2004, 35:656-663.
7. Suarez F., Rothhut B., Comera C., Touqui L., Marie F.R., Silve C. Expression of annexin I, II, V, and VI by rat osteoblasts in primary culture: stimulation of annexin I expression by dexamethasone. J Bone Miner Res 1993, 8:1201-1210.
8. Maier S.M., Scherer S.J., Seifert M., Hanselmann R.G., Schleehuber Y., Edelmann L., Reichrath J., Krohne G., Rescher U., Seidl W., Mutschler W., Claes L., Welter C., Schartl M. 1[alpha], 25-Dihydroxyvitamin D(3) enhances annexin II dependent proliferation of osteoblasts. J Cell Biochem 2007, 100:679-692.
9. Boyan B.D., Bonewald L.F., Sylvia V.L., Nemere I., Larsson D., Norman A.W., Rosser J., Dean D.D., Schwartz Z. Evidence for distinct membrane receptors for 1 alpha, 25-(OH)(2)D(3) and 24R, 25-(OH)(2)D(3) in osteoblasts. Steroids 2002, 67:235-246.
10. Xiao G.S., Jin Y.S., Lu Q.Y., Zhang Z.F., Belldegrun A., Figlin R., Pantuck A., Yen Y., Li F., Rao J. Annexin-I as a potential target for green tea extract induced actin remodeling. Int J Cancer 2007, 120:111-120.
11. Thouverey C., Strzelecka-Kiliszek A., Balcerzak M., Buchet R., Pikula S. Matrix vesicles originate from apical membrane microvilli of mineralizing osteoblast-like Saos-2 cells. J Cell Biochem 2009, 106:127-138.
12. Gillette J.M., Nielsen-Preiss S.M. The role of annexin 2 in osteoblastic mineralization. J Cell Sci 2004, 117:441-449.
13. Silva W.A., Covas D.T., Panepucci R.A., Proto-Siqueira R., Siufi J.L., Zanette D.L., Santos A.R., Zago M.A. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 2003, 21:661-669.
14. Yi W., Sun Y., Wei X., Gu C., Dong X., Kang X., Guo S., Dou K. Proteomic profiling of human bone marrow mesenchymal stem cells under shear stress. Mol Cell Biochem 2010, 341(1-2):9-16.
15. Panepucci R.A., Siufi J.L., Silva W.A., Proto-Siquiera R., Neder L., Orellana M., Rocha V., Covas D.T., Zago M.A. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 2004, 22:1263-1278.
16. Wang W., Kirsch T. Retinoic acid stimulates annexin-mediated growth plate chondrocyte mineralization. J Cell Biol 2002, 157:1061-1069.
17. Chen N.X., O'Neill K.D., Chen X., Moe S.M. Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res 2008, 23:1798-1805.
18. Tuszynski G.P., Sharma M.R., Rothman V.L., Sharma M.C. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells. Microvasc Res 2002, 64:448-462.
19. Kim J., Hajjar K.A. Annexin II: a plasminogen-plasminogen activator co-receptor. Front Biosci 2002, 7:d341-d348.
20. Sharma M.C., Sharma M. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target. Curr Pharm Des 2007, 13:3568-3575.
21. Bao H., Jiang M., Zhu M., Sheng F., Ruan J., Ruan C. Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma. Int J Hematol 2009, 90:177-185.
22. Sharma M., Ownbey R.T., Sharma M.C. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation. Exp Mol Pathol 2010, 88:278-286.
23. Zhao S., Huang L., Wu J., Zhang Y., Pan D., Liu X. Vascular endothelial growth factor upregulates expression of Annexin A2 in vitro and in a mouse model of ischemic retinopathy. Mol Vis 2009, 15:1231-1242.
24. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
25. Genetos D.C., Lee C.M., Wong A., Yellowley C.E. HIF-1alpha regulates hypoxia-induced EP1 expression in osteoblastic cells. J Cell Biochem 2009, 107:233-239.
26. 2 tension. Am J Physiol 1996, 271:C1172-C1180.
27. Semenza G.L., Jiang B.H., Leung S.W., Passantino R., Concordet J.P., Maire P., Giallongo A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996, 271:32529-32537.
28. Genetos D.C., Toupadakis C.A., Raheja L.F., Wong A., Papanicolaou S.E., Fyhrie D.P., Loots G.G., Yellowley C.E. Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts. J Cell Biochem 2010, 110:457-467.
29. Steinbrech D.S., Mehrara B.J., Saadeh P.B., Chin G., Dudziak M.E., Gerrets R.P., Gittes G.K., Longaker M.T. Hypoxia regulates VEGF expression and cellular proliferation by osteoblasts in vitro. Plast Reconstr Surg 1999, 104:738-747.
30. Steinbrech D.S., Mehrara B.J., Saadeh P.B., Greenwald J.A., Spector J.A., Gittes G.K., Longaker M.T. VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism. Am J Physiol Cell Physiol 2000, 278:C853-C860.
31. Bello L., Lucini V., Costa F., Pluderi M., Giussani C., Acerbi F., Carrabba G., Pannacci M., Caronzolo D., Grosso S., Shinkaruk S., Colleoni F., Canron X., Tomei G., Deleris G., Bikfalvi A. Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma. Clin Cancer Res 2004, 10:4527-4537.
32. Zilberberg L., Shinkaruk S., Lequin O., Rousseau B., Hagedorn M., Costa F., Caronzolo D., Balke M., Canron X., Convert O., Lain G., Gionnet K., Goncalves M., Bayle M., Bello L., Chassaing G., Deleris G., Bikfalvi A. Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor. J Biol Chem 2003, 278:35564-35573.
33. Olsson A.K., Dimberg A., Kreuger J., Claesson-Welsh L. VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 2006, 7:359-371.
34. PAK, p38 mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes. Biochem Biophys Res Commun 1997, 239:840-844.
35. Peng X.H., Karna P., Cao Z., Jiang B.H., Zhou M., Yang L. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem 2006, 281:25903-25914.
36. Kanichai M., Ferguson D., Prendergast P.J., Campbell V.A. Hypoxia promotes chondrogenesis in rat mesenchymal stem cells: a role for AKT and hypoxia-inducible factor (HIF)-1alpha. J Cell Physiol 2008, 216:708-715.
37. 2 and pH in the anaesthetized dog. Acta Orthop Scand 1979, 50:645-651.
38. Eriksen J., Tondevold E., Jansen E., Petersen J.E. Relationships between oxygen and carbon dioxide tensions and acid-base balance in arterial blood and in medullary blood from long bones in dogs. Acta Orthop Scand 1979, 50:519-525.
39. Gronlund J., Kofoed H., Svalastoga E. Effect of increased knee joint pressure on oxygen tension and blood flow in subchondral bone. Acta Physiol Scand 1984, 121:127-131.
40. Kiaer T., Dahl B., Lausten G. Partial pressures of oxygen and carbon dioxide in bone and their correlation with bone-blood flow: effect of decreased arterial supply and venous congestion on intraosseous oxygen and carbon dioxide in an animal model. J Orthop Res 1992, 10:807-812.
41. Brighton C.T., Krebs A.G. Oxygen tension of healing fractures in the rabbit. J Bone Joint Surg Am 1972, 54:323-332.
42. Heppenstall R.B., Goodwin C.W., Brighton C.T. Fracture healing in the presence of chronic hypoxia. J Bone Joint Surg Am 1976, 58:1153-1156.
43. Webster K.A. Evolution of the coordinate regulation of glycolytic enzyme genes by hypoxia. J Exp Biol 2003, 206:2911-2922.
44. Street J., Bao M., deGuzman L., Bunting S., Peale F.V., Ferrara N., Steinmetz H., Hoeffel J., Cleland J.L., Daugherty A., van Bruggen N., Redmond H.P., Carano R.A., Filvaroff E.H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002, 99:9656-9661.
45. Wang Y., Wan C., Deng L., Liu X., Cao X., Gilbert S.R., Bouxsein M.L., Faugere M.C., Guldberg R.E., Gerstenfeld L.C., Haase V.H., Johnson R.S., Schipani E., Clemens T.L. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 2007, 117:1616-1626.
46. Street J., Lenehan B. Vascular endothelial growth factor regulates osteoblast survival-evidence for an autocrine feedback mechanism. J Orthop Surg Res 2009, 4:19.
47. Mayr-Wohlfart U., Waltenberger J., Hausser H., Kessler S., Gunther K.P., Dehio C., Puhl W., Brenner R.E. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 2002, 30:472-477.
48. Tepper O.M., Capla J.M., Galiano R.D., Ceradini D.J., Callaghan M.J., Kleinman M.E., Gurtner G.C. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005, 105:1068-1077.
49. Deckers M.M., Karperien M., van der Bent C., Yamashita T., Papapoulos S.E., Lowik C.W. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 2000, 141:1667-1674.
50. Deckers M.M., van Bezooijen R.L., van der Horst G., Hoogendam J., van Der Bent C., Papapoulos S.E., Lowik C.W. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002, 143:1545-1553.
51. Mayer H., Bertram H., Lindenmaier W., Korff T., Weber H., Weich H. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 2005, 95:827-839.
52. Harper J., Gerstenfeld L.C., Klagsbrun M. Neuropilin-1 expression in osteogenic cells: down-regulation during differentiation of osteoblasts into osteocytes. J Cell Biochem 2001, 81:82-92.
53. Veikkola T., Karkkainen M., Claesson-Welsh L., Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 2000, 60:203-212.
54. Vanderkooi J.M., Erecinska M., Silver I.A. Oxygen in mammalian tissue: methods of measurement and affinities of various reactions. Am J Physiol 1991, 260:C1131-C1150.
55. Silver I.A. Measurement of pH and ionic composition of pericellular sites. Philos Trans R Soc Lond B Biol Sci 1975, 271:261-272.
56. Zahm A.M., Bucaro M.A., Ayyaswamy P.S., Srinivas V., Shapiro I.M., Adams C.S., Mukundakrishnan K. Numerical modeling of oxygen distributions in cortical and cancellous bone: oxygen availability governs osteonal and trabecular dimensions. Am J Physiol Cell Physiol 2010, [Electronic publication ahead of print], doi:10.1152/ajpcell.00465.2009.
57. Schipani E., Ryan H.E., Didrickson S., Kobayashi T., Knight M., Johnson R.S. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 2001, 15:2865-2876.
58. Dodd J.S., Raleigh J.A., Gross T.S. Osteocyte hypoxia: a novel mechanotransduction pathway. Am J Physiol 1999, 277:C598-C602.
59. Komatsu D.E., Hadjiargyrou M. Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. Bone 2004, 34:680-688.
60. Epari D.R., Lienau J., Schell H., Witt F., Duda G.N. Pressure, oxygen tension and temperature in the periosteal callus during bone healing-an in vivo study in sheep. Bone 2008, 43:734-739.
61. Lee C.M., Genetos D.C., You Z., Yellowley C.E. Hypoxia regulates PGE(2) release and EP1 receptor expression in osteoblastic cells. J Cell Physiol 2007, 212:182-188.
62. Raheja LF, Genetos DC, Yellowley CE. The effect of oxygen tension on the long-term osteogenic differentiation and MMP/TIMP expression of human mesenchymal stem cells. Cells Tissues Organs 2010;191(3):175-84.
63. Jung Y., Wang J., Song J., Shiozawa Y., Havens A., Wang Z., Sun Y.X., Emerson S.G., Krebsbach P.H., Taichman R.S. Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation. Blood 2007, 110:82-90.